Citi analyst David Lebowitz lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $44.00 (from $45.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Pliant Therapeutics (PLRX) PT Lowered to $45 at RBC CapitalMay 7, 2024 6:19 AM Pliant Therapeutics, Inc. (PLRX) Misses Q1 EPS by 1cMay 6, 2024 5:39 PM Form 10-Q PLIANT THERAPEUTICS, For: Mar 31May 6, 2024 4:28 PM Form 8-K PLIANT THERAPEUTICS, For: May 06May 6, 2024 4:11 PM Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 6, 2024 4:05 PM Form 4 PLIANT THERAPEUTICS, For: May 02 Filed by: Cummings Keith LamontMay 6, 2024 6:13 AM